Evidence map›Paper›PMID 42394893›Full record

ArticleNordisk alkohol- & narkotikatidskrift : NAT2026

Representation of Substance Use Issues in Old Age Within Norwegian Policy Frameworks.

Gloria Abena Ampim, Gudmund Ågotnes

Abstract read
In one paragraph

Article in Nordisk alkohol- & narkotikatidskrift : NAT, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Changing Worlds, Changing Drug Markets.Nordisk alkohol- & narkotikatidskrift : NAT · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gloria Abena AmpimDepartment of Welfare and Participation, Western Norway University of Applied Sciences, Bergen, Norway.ORCID https://orcid.org/0000-0003-0514-3812
Gudmund ÅgotnesDepartment of Welfare and Participation, Western Norway University of Applied Sciences, Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: This study examines how national policies have framed substance use issues among older adults in Norway. Methods: An analysis of 18 Norwegian white papers published between 2003 and 2024 by the Ministry of Health and Care Services, the Ministry of Social Affairs, and related ministries was conducted through "What Is the Problem Represented to Be?" poststructural analysis. Results: White papers acknowledge increasing alcohol and substance use among older adults and depict these developments as significant challenges for health and social services both at present and in the future. In response, the following three strategies are proposed: promoting active aging to address inactivity, which can contribute to substance use; combating loneliness and isolation, which represent both the causes and consequences of substance use among elderly individuals; and implementing preventive home visits to help older individuals manage daily challenges and recognize early signs of harmful substance use. Conclusions: Relevant policies primarily address alcohol and prescription drugs but largely ignore the so-called illicit substances. The strategies employed constitute a funnel, leading from broad and preventive strategies to narrow and curative strategies. Although this variation holds some promise, we argue that these policies inadvertently portray substance use in older adults as if all individuals with substance use problems share the same characteristics, experiences, and needs. This generalization risks exacerbating health inequalities among older adults who use substances.

Indexed as

discourse analysisNorwayolder adultssubstance use

Identifiers

PMID42394893
PMCPMC13323042

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.